Clinical Trials

Click here to go to clinicaltrials.gov

 

View Tips and Talking Points for Supporting a Patient’s Decision
to Enroll in a Clinical Trial Here

 

Featured Clinical Trials

Yttrium-90 Radioembolization in Combination with Tremelimumab and Durvalumab for Treating Patients with Locally Advanced, Unresectable or Oligo-metastatic Intrahepatic Cholangiocarcinoma Who are Not Candidates for Curative Therapy, RAIDEN Trial

This phase I trial tests the safety and side effects of yttrium-90 (Y90) radioembolization combined with immunotherapy drugs tremelimumab and durvalumab in treating patients with intrahepatic cholangiocarcinoma (cancer of the bile ducts in the liver) that has spread to nearby tissue or lymph nodes (locally advanced) and cannot be removed by surgery (unresectable) who are... Read More »

© 2021 FLASCO | Premium Website Design by The HDG